News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,824 Results
Type
Article (530)
Company Profile (2)
Press Release (24292)
Section
Business (13632)
Career Advice (11)
Deals (1887)
Drug Development (1874)
FDA (484)
Job Trends (699)
News (17176)
Policy (1155)
Tag
Academia (98)
Allergies (23)
Alliances (858)
ALS (2)
Alzheimer's disease (12)
Antibody-drug conjugate (ADC) (17)
Approvals (521)
Artificial intelligence (1)
Autoimmune disease (7)
Automation (1)
Bankruptcy (5)
Best Places to Work (692)
Biosimilars (1)
Biotechnology (1)
Bladder cancer (9)
Breast cancer (54)
Cancer (136)
Cardiovascular disease (6)
Career advice (12)
Cell therapy (6)
Clinical research (1844)
Collaboration (17)
Compensation (15)
COVID-19 (30)
C-suite (3)
Cystic fibrosis (2)
Data (228)
Depression (1)
Diabetes (11)
Diagnostics (388)
Digital health (2)
Drug discovery (1)
Drug pricing (1)
Earnings (12907)
Editorial (1)
Events (2423)
Executive appointments (4)
FDA (701)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (12)
Gene editing (1)
Gene therapy (2)
GLP-1 (24)
Government (212)
Guidances (131)
Healthcare (1463)
HIV (4)
IgA nephropathy (5)
Immunology and inflammation (3)
Immuno-oncology (1)
Indications (1)
Infectious disease (31)
Inflammatory bowel disease (5)
Intellectual property (4)
Interviews (3)
IPO (1489)
Job creations (51)
Job search strategy (9)
Layoffs (11)
Leadership (1)
Legal (328)
Liver cancer (1)
Lung cancer (15)
Lymphoma (7)
Manufacturing (3)
MASH (4)
Medical device (899)
Medtech (901)
Mergers & acquisitions (422)
Metabolic disorders (29)
Multiple sclerosis (18)
Neurodegenerative disease (8)
Neuroscience (47)
NextGen: Class of 2026 (346)
Non-profit (189)
Obesity (17)
Opinion (1)
Ovarian cancer (2)
Pain (1)
Pancreatic cancer (3)
Parkinson's disease (7)
Patents (6)
Patient recruitment (4)
Peanut (7)
People (748)
Pharmaceutical (1)
Phase 1 (353)
Phase 2 (616)
Phase 3 (967)
Pipeline (518)
Policy (1)
Postmarket research (80)
Preclinical (87)
Press Release (1)
Prostate cancer (4)
Radiopharmaceuticals (3)
Rare diseases (17)
Real estate (118)
Regulatory (740)
Research institute (112)
Rett syndrome (1)
RNA editing (1)
RSV (1)
Schizophrenia (3)
Series A (2)
Series B (1)
Sickle cell disease (2)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (60)
Stomach cancer (1)
Supply chain (3)
Tariffs (2)
Vaccines (7)
Weight loss (9)
Women's health (3)
Date
Today (5)
Last 7 days (22)
Last 30 days (52)
Last 365 days (1454)
2026 (58)
2025 (1471)
2024 (1602)
2023 (1951)
2022 (2069)
2021 (2033)
2020 (1979)
2019 (1306)
2018 (4661)
2017 (921)
2016 (596)
2015 (914)
2014 (663)
2013 (394)
2012 (455)
2011 (574)
2010 (562)
Location
Africa (13)
Alabama (3)
Arizona (12)
Asia (1676)
Australia (62)
California (481)
Canada (114)
China (42)
Colorado (29)
Connecticut (12)
Delaware (30)
Europe (2409)
Florida (86)
Georgia (27)
Hawaii (1)
Illinois (31)
India (2)
Indiana (39)
Japan (25)
Kansas (7)
Kentucky (2)
Louisiana (6)
Maine (11)
Maryland (54)
Massachusetts (289)
Michigan (14)
Minnesota (33)
Missouri (10)
Montana (2)
Nevada (6)
New Hampshire (6)
New Jersey (225)
New York (206)
North Carolina (75)
Northern California (239)
Ohio (6)
Oregon (1)
Pennsylvania (122)
Puerto Rico (2)
Rhode Island (1)
South America (35)
South Carolina (1)
Southern California (208)
Tennessee (5)
Texas (63)
United States (1914)
Utah (14)
Virginia (4)
Washington D.C. (2)
Washington State (30)
Wisconsin (2)
24,824 Results for "187".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cell and Gene Therapy Market Size to Surge USD 187.44 Billion by 2034
February 20, 2025
·
1 min read
Press Releases
U.S. Life Science Tools Market Size to Reach USD 187.03 Billion by 2034
February 25, 2025
·
1 min read
Press Releases
Peritoneal Cancer Market Expected to Grow at a CAGR of 18.7% during 2025-2035, Impelled by Advancements in Diagnostic Techniques
February 7, 2025
·
8 min read
Press Releases
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
March 3, 2025
·
4 min read
BioCapital
Zeteo Tech Awarded $1.87M DHS Science & Technology Directorate Contract to Develop and Test the Next Generation of the digitalMALDI® Real-Time Biological Threat Detection Technology
Zeteo Tech, Inc. announced that it has been awarded a Phase III Small Business Innovation Research contract for $1.87M with a potential value of up to $5.86 million from the U.S. Department of Homeland Security.
December 12, 2023
·
3 min read
Press Releases
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
January 20, 2025
·
4 min read
Press Releases
EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting
November 22, 2024
·
4 min read
Stem Cell Therapy Market Size To Hold USD 18.7 Bn By 2030
The global stem cell therapy market size was exhibited at USD 10.51 billion in 2022 and is expected to hold around USD 18.7 billion by 2030, growing at a CAGR of 7.47% from 2022 to 2030.
December 8, 2022
·
8 min read
StageZero Life Sciences Announces Closing of CAD$1.87 Million Private Placement with Institutional Investor
StageZero Life Sciences, Ltd. is pleased to announce that it has closed its previously announced private placement of its common shares and warrants to purchase Common Shares with an institutional investor for gross proceeds of approximately CAD$1.87 million.
March 3, 2022
·
4 min read
BioMADE Announces Nine Projects, $18.7 Million to Advance Domestic Bioindustrial Manufacturing and DoD Sustainability Goals
BioMADE today announced nine new leading-edge projects that will advance Department of Defense supply chain resiliency and sustainability goals, re-shore manufacturing jobs to the U.S
September 14, 2023
·
6 min read
1 of 2,483
Next
